Balyasny Asset Management LLC lowered its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 92.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 10,248 shares of the pharmacy operator’s stock after selling 130,978 shares during the quarter. Balyasny Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $434,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Public Employees Retirement Association of Colorado lifted its holdings in Walgreens Boots Alliance by 3.2% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 143,590 shares of the pharmacy operator’s stock worth $6,569,000 after buying an additional 4,471 shares in the last quarter. Chicago Equity Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the first quarter valued at $223,000. Russell Investments Group Ltd. boosted its holdings in Walgreens Boots Alliance by 29.9% in the first quarter. Russell Investments Group Ltd. now owns 408,486 shares of the pharmacy operator’s stock valued at $18,586,000 after acquiring an additional 94,002 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Walgreens Boots Alliance by 14.7% in the first quarter. Oppenheimer Asset Management Inc. now owns 188,818 shares of the pharmacy operator’s stock valued at $8,639,000 after acquiring an additional 24,212 shares during the last quarter. Finally, Mackay Shields LLC increased its position in Walgreens Boots Alliance by 55.3% in the first quarter. Mackay Shields LLC now owns 219,471 shares of the pharmacy operator’s stock worth $10,041,000 after purchasing an additional 78,156 shares during the period. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Shares of WBA stock opened at $35.27 on Wednesday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.33 and a current ratio of 0.69. Walgreens Boots Alliance Inc has a 52 week low of $33.88 and a 52 week high of $64.50. The company’s 50 day moving average price is $39.37 and its two-hundred day moving average price is $42.21. The company has a market capitalization of $30.42 billion, a P/E ratio of 43.01, a price-to-earnings-growth ratio of 1.35 and a beta of 0.43.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.10 by ($0.27). The company had revenue of $34.63 billion for the quarter, compared to the consensus estimate of $34.32 billion. Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The firm’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the company earned $1.47 EPS. Analysts forecast that Walgreens Boots Alliance Inc will post 4.68 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Wednesday, August 19th were issued a $0.4675 dividend. This represents a $1.87 dividend on an annualized basis and a dividend yield of 5.30%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. The ex-dividend date was Tuesday, August 18th. Walgreens Boots Alliance’s payout ratio is 31.22%.

Several research analysts have recently issued reports on the stock. Cowen reduced their target price on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating on the stock in a research note on Tuesday, May 19th. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 target price for the company. in a report on Friday, July 17th. Deutsche Bank cut their price target on Walgreens Boots Alliance from $43.00 to $38.00 and set a “hold” rating on the stock in a research note on Friday, July 10th. ValuEngine lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Wednesday, May 27th. Finally, Bank of America dropped their price objective on Walgreens Boots Alliance from $43.00 to $40.00 and set an “underperform” rating for the company in a report on Friday, July 10th. Four analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $44.60.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: Capital Gains

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.